Blockchain Registration Transaction Record

Oncotelic's PDAOAI: A New Era in Transparent Drug Discovery

Oncotelic Therapeutics launches PDAOAI, an evidence-interrogation platform that indexes 125,000+ abstracts on TGF-β signaling, enabling transparent, auditable hypothesis generation for drug discovery.

This news matters because it highlights a tangible solution to a persistent problem in biomedical research: the lack of transparency and reproducibility in AI-driven hypothesis generation. With PDAOAI, researchers can move away from black-box models and toward auditable, evidence-based discovery, which could accelerate drug development and reduce costly failures. For investors, Oncotelic’s positioning alongside industry giants like Thermo Fisher and Danaher signals its potential to play a key role in the pharmaceutical sector’s AI transformation.